Edith Lord
Concepts (425)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Melanoma, Experimental | 6 | 1999 | 13 |
Why?
| T-Lymphocytes, Cytotoxic | 15 | 1990 | 52 |
Why?
| Neoplasms, Experimental | 14 | 1980 | 72 |
Why?
| Mice, Inbred BALB C | 51 | 1980 | 176 |
Why?
| Interleukin-12 | 5 | 1999 | 27 |
Why?
| Sarcoma, Experimental | 11 | 1979 | 21 |
Why?
| Mice | 87 | 1975 | 623 |
Why?
| Interleukin-2 | 10 | 1993 | 71 |
Why?
| Etanidazole | 17 | 1993 | 4 |
Why?
| Interferon-gamma | 11 | 1988 | 133 |
Why?
| Mammary Neoplasms, Experimental | 12 | 1979 | 37 |
Why?
| Lymphocytes, Tumor-Infiltrating | 10 | 1993 | 20 |
Why?
| Histocompatibility Antigens Class I | 12 | 1990 | 32 |
Why?
| Hydrocarbons, Fluorinated | 15 | 1995 | 5 |
Why?
| Cell Hypoxia | 18 | 1993 | 31 |
Why?
| Gamma Rays | 3 | 2001 | 38 |
Why?
| Interleukin-3 | 6 | 1993 | 19 |
Why?
| Lung Neoplasms | 15 | 1984 | 159 |
Why?
| Animals | 100 | 1975 | 1031 |
Why?
| Cytotoxicity, Immunologic | 17 | 1980 | 54 |
Why?
| Antigens, Neoplasm | 9 | 1984 | 56 |
Why?
| Neovascularization, Pathologic | 6 | 1995 | 64 |
Why?
| Oxygen | 11 | 1995 | 179 |
Why?
| Cell Movement | 7 | 1980 | 163 |
Why?
| Dendritic Cells | 5 | 1997 | 60 |
Why?
| Antibodies, Monoclonal | 17 | 1984 | 241 |
Why?
| Antigen Presentation | 6 | 1996 | 28 |
Why?
| Mice, Inbred C57BL | 22 | 1980 | 318 |
Why?
| Transfection | 17 | 1987 | 237 |
Why?
| Antigen-Presenting Cells | 7 | 1996 | 40 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2003 | 9 |
Why?
| Anoxia | 10 | 1990 | 85 |
Why?
| T-Lymphocytes | 11 | 1975 | 182 |
Why?
| Carcinoma | 8 | 1985 | 109 |
Why?
| Tumor Cells, Cultured | 21 | 1987 | 233 |
Why?
| Growth Inhibitors | 2 | 1985 | 33 |
Why?
| Killer Cells, Natural | 7 | 1985 | 62 |
Why?
| Antibodies, Neoplasm | 2 | 1998 | 28 |
Why?
| Langerhans Cells | 1 | 2009 | 13 |
Why?
| Lymphocyte Activation | 6 | 1977 | 137 |
Why?
| Oxyhemoglobins | 3 | 1998 | 10 |
Why?
| Recombinant Proteins | 9 | 1989 | 290 |
Why?
| Macrophages | 7 | 1979 | 148 |
Why?
| Neoplasm Transplantation | 16 | 1980 | 67 |
Why?
| Mice, Transgenic | 10 | 1997 | 209 |
Why?
| H-2 Antigens | 7 | 1985 | 12 |
Why?
| Omentum | 1 | 2006 | 12 |
Why?
| Antigen-Antibody Complex | 1 | 2006 | 34 |
Why?
| Peritoneal Neoplasms | 1 | 2006 | 24 |
Why?
| Prostate-Specific Antigen | 8 | 1996 | 34 |
Why?
| Flow Cytometry | 8 | 1984 | 216 |
Why?
| Cell Separation | 8 | 1980 | 110 |
Why?
| Cytokines | 3 | 1995 | 207 |
Why?
| Cell Line, Tumor | 4 | 2005 | 208 |
Why?
| Radiation-Sensitizing Agents | 5 | 1995 | 29 |
Why?
| Lymphoid Tissue | 1 | 2005 | 34 |
Why?
| Mice, Knockout | 5 | 1997 | 265 |
Why?
| Gene Expression Regulation | 1 | 2010 | 277 |
Why?
| Prostate | 2 | 1998 | 55 |
Why?
| Antineoplastic Agents | 7 | 1995 | 190 |
Why?
| Microscopy, Fluorescence | 4 | 1997 | 137 |
Why?
| Radiation Tolerance | 3 | 1996 | 37 |
Why?
| Ovalbumin | 6 | 1996 | 32 |
Why?
| Dimethyl Sulfoxide | 6 | 1985 | 30 |
Why?
| Transforming Growth Factor beta | 3 | 1993 | 99 |
Why?
| Lymph Nodes | 5 | 1998 | 106 |
Why?
| Graft Rejection | 5 | 1980 | 59 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1995 | 53 |
Why?
| Immunophenotyping | 3 | 1999 | 66 |
Why?
| Mice, Inbred C3H | 9 | 1993 | 86 |
Why?
| Histocompatibility Antigens Class II | 4 | 1981 | 50 |
Why?
| Neoplasm Metastasis | 4 | 1982 | 112 |
Why?
| Immunohistochemistry | 11 | 1996 | 355 |
Why?
| Antigens, CD80 | 2 | 1995 | 19 |
Why?
| Nitroimidazoles | 2 | 1993 | 6 |
Why?
| Spleen | 8 | 1975 | 129 |
Why?
| Indicators and Reagents | 4 | 1995 | 79 |
Why?
| Gene Transfer Techniques | 1 | 2000 | 59 |
Why?
| Mice, Nude | 4 | 1997 | 72 |
Why?
| Fluorescent Dyes | 4 | 1987 | 115 |
Why?
| Image Processing, Computer-Assisted | 2 | 1999 | 138 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1998 | 32 |
Why?
| Endothelial Growth Factors | 4 | 1995 | 47 |
Why?
| Dose-Response Relationship, Radiation | 2 | 2005 | 85 |
Why?
| Female | 31 | 1977 | 1643 |
Why?
| Peritoneal Cavity | 5 | 1979 | 28 |
Why?
| Hybridomas | 6 | 1984 | 31 |
Why?
| Skin | 2 | 2008 | 177 |
Why?
| Spheroids, Cellular | 1 | 1996 | 5 |
Why?
| Neoplasms | 3 | 1998 | 239 |
Why?
| Immunoconjugates | 1 | 1995 | 11 |
Why?
| Vascular Endothelial Growth Factor A | 4 | 1995 | 94 |
Why?
| Fibrosarcoma | 3 | 1997 | 18 |
Why?
| Hyperthermia, Induced | 1 | 1995 | 12 |
Why?
| Immunization | 6 | 1975 | 85 |
Why?
| Adenocarcinoma, Bronchiolo-Alveolar | 2 | 1984 | 9 |
Why?
| Cell Line | 13 | 1981 | 375 |
Why?
| Mammary Neoplasms, Animal | 2 | 1990 | 13 |
Why?
| Cell Communication | 2 | 1997 | 72 |
Why?
| Herpesvirus 1, Human | 2 | 2001 | 28 |
Why?
| Antigens, CD8 | 2 | 1992 | 25 |
Why?
| Fluorescent Antibody Technique | 5 | 1984 | 164 |
Why?
| Immunity, Cellular | 5 | 1977 | 85 |
Why?
| Endothelium, Vascular | 2 | 2003 | 139 |
Why?
| Antigens, CD4 | 1 | 1992 | 29 |
Why?
| Disease Models, Animal | 4 | 1980 | 349 |
Why?
| Image Enhancement | 2 | 1998 | 70 |
Why?
| Immunotherapy | 5 | 1993 | 48 |
Why?
| Genes, MHC Class I | 2 | 1988 | 11 |
Why?
| Cell Count | 2 | 1987 | 163 |
Why?
| Phenotype | 3 | 1996 | 303 |
Why?
| Lymphokines | 3 | 1995 | 61 |
Why?
| Cytotoxicity Tests, Immunologic | 3 | 1989 | 23 |
Why?
| Carcinoma, Squamous Cell | 3 | 1993 | 111 |
Why?
| Tissue Kallikreins | 2 | 1998 | 7 |
Why?
| Epitopes, T-Lymphocyte | 2 | 2000 | 17 |
Why?
| Fluorescence | 2 | 1995 | 46 |
Why?
| Adjuvants, Immunologic | 2 | 2001 | 73 |
Why?
| Cell Survival | 6 | 1981 | 229 |
Why?
| Skin Neoplasms | 2 | 1993 | 97 |
Why?
| Receptors, Interleukin-12 | 1 | 2009 | 5 |
Why?
| Time Factors | 6 | 1980 | 896 |
Why?
| Antigens | 3 | 1975 | 66 |
Why?
| Blood Vessels | 3 | 1998 | 65 |
Why?
| Mice, Inbred Strains | 5 | 1977 | 118 |
Why?
| Cell Cycle | 4 | 1981 | 121 |
Why?
| Lymphocytes | 4 | 1977 | 142 |
Why?
| Green Fluorescent Proteins | 3 | 2001 | 105 |
Why?
| Immunosuppression | 3 | 1975 | 47 |
Why?
| Microscopy, Confocal | 1 | 2009 | 105 |
Why?
| Hemolytic Plaque Technique | 3 | 1975 | 6 |
Why?
| Benzimidazoles | 1 | 1987 | 16 |
Why?
| Vascular Endothelial Growth Factors | 3 | 1995 | 39 |
Why?
| Clone Cells | 5 | 1980 | 92 |
Why?
| Isoantigens | 1 | 2007 | 18 |
Why?
| Prostatic Neoplasms | 4 | 1996 | 120 |
Why?
| Bone Marrow Cells | 2 | 1998 | 92 |
Why?
| Skin Transplantation | 1 | 2007 | 39 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2006 | 27 |
Why?
| Models, Immunological | 1 | 2006 | 40 |
Why?
| Glioma | 3 | 1995 | 51 |
Why?
| Radiobiology | 2 | 1996 | 9 |
Why?
| Epithelium | 1 | 2006 | 101 |
Why?
| Centrifugation | 3 | 1981 | 27 |
Why?
| Genes, Reporter | 1 | 2007 | 111 |
Why?
| Cell Proliferation | 2 | 2005 | 227 |
Why?
| Up-Regulation | 1 | 2008 | 183 |
Why?
| Gene Expression | 3 | 1993 | 291 |
Why?
| Xenopus laevis | 1 | 2007 | 49 |
Why?
| Rats | 10 | 1981 | 530 |
Why?
| Mice, Inbred A | 1 | 2005 | 15 |
Why?
| Peyer's Patches | 1 | 2005 | 7 |
Why?
| Luminescent Proteins | 2 | 2001 | 67 |
Why?
| Lymphocyte Count | 1 | 2005 | 38 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2005 | 26 |
Why?
| Epitopes | 4 | 1975 | 86 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 1989 | 210 |
Why?
| Ovarian Neoplasms | 1 | 1986 | 64 |
Why?
| Host vs Graft Reaction | 1 | 1984 | 2 |
Why?
| Plasmids | 2 | 2001 | 122 |
Why?
| Immunologic Techniques | 1 | 1984 | 19 |
Why?
| Mice, Inbred DBA | 3 | 1980 | 38 |
Why?
| Antigens, Surface | 4 | 1981 | 51 |
Why?
| Chemokine CXCL10 | 1 | 2003 | 22 |
Why?
| Male | 15 | 1977 | 1553 |
Why?
| Vascular Endothelial Growth Factor D | 1 | 2003 | 6 |
Why?
| Kinetics | 7 | 1980 | 349 |
Why?
| Vascular Endothelial Growth Factor C | 1 | 2003 | 13 |
Why?
| Cell Division | 3 | 1982 | 273 |
Why?
| B-Lymphocytes | 2 | 1981 | 134 |
Why?
| Autoantigens | 2 | 1975 | 29 |
Why?
| Mast-Cell Sarcoma | 2 | 1980 | 9 |
Why?
| Cell Death | 1 | 2003 | 94 |
Why?
| Freezing | 2 | 1984 | 26 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 64 |
Why?
| Immunoglobulin G | 3 | 1984 | 191 |
Why?
| Lymphocyte Culture Test, Mixed | 2 | 1977 | 21 |
Why?
| Apoptosis | 2 | 1997 | 265 |
Why?
| Interleukin-4 | 2 | 1993 | 62 |
Why?
| Borates | 1 | 2001 | 6 |
Why?
| Myocardial Infarction | 2 | 1997 | 129 |
Why?
| Calcium Compounds | 1 | 2001 | 6 |
Why?
| Carbocyanines | 2 | 1998 | 13 |
Why?
| Histidine | 1 | 2001 | 42 |
Why?
| Biological Transport | 2 | 1999 | 129 |
Why?
| Peptides | 2 | 2000 | 154 |
Why?
| Enterotoxins | 1 | 2001 | 15 |
Why?
| Cancer Vaccines | 1 | 2001 | 21 |
Why?
| Humans | 18 | 1975 | 1856 |
Why?
| CpG Islands | 1 | 2001 | 26 |
Why?
| Capsid Proteins | 1 | 2001 | 19 |
Why?
| Oncogene Proteins, Viral | 1 | 2001 | 29 |
Why?
| Escherichia coli | 2 | 2001 | 143 |
Why?
| Regulatory Sequences, Nucleic Acid | 2 | 1997 | 43 |
Why?
| Vaccines, Synthetic | 1 | 2001 | 30 |
Why?
| Bacterial Toxins | 1 | 2001 | 24 |
Why?
| Conjunctiva | 1 | 2000 | 19 |
Why?
| Fluorine Radioisotopes | 1 | 2000 | 7 |
Why?
| Viral Vaccines | 1 | 2001 | 35 |
Why?
| Clonal Anergy | 1 | 2000 | 20 |
Why?
| Escherichia coli Proteins | 1 | 2001 | 40 |
Why?
| Papillomaviridae | 1 | 2001 | 37 |
Why?
| Carbon Dioxide | 2 | 1996 | 90 |
Why?
| Growth Plate | 2 | 1997 | 27 |
Why?
| Major Histocompatibility Complex | 1 | 1999 | 23 |
Why?
| Immune Tolerance | 1 | 2000 | 72 |
Why?
| Melanoma | 1 | 2001 | 87 |
Why?
| Models, Biological | 4 | 1980 | 410 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 1993 | 113 |
Why?
| Microspheres | 2 | 1993 | 40 |
Why?
| Ductus Arteriosus, Patent | 1 | 1999 | 13 |
Why?
| Uterine Cervical Neoplasms | 1 | 2000 | 55 |
Why?
| Head and Neck Neoplasms | 1 | 2000 | 47 |
Why?
| ATP-Binding Cassette Transporters | 1 | 1999 | 33 |
Why?
| Oxygen Consumption | 1 | 2000 | 86 |
Why?
| Cells, Cultured | 4 | 1980 | 447 |
Why?
| Ischemic Attack, Transient | 1 | 1999 | 28 |
Why?
| Hybridization, Genetic | 1 | 1998 | 12 |
Why?
| Colonic Neoplasms | 2 | 1995 | 63 |
Why?
| Erythrocytes | 3 | 1975 | 109 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 1995 | 224 |
Why?
| Myocardium | 2 | 1997 | 119 |
Why?
| Cricetinae | 3 | 1987 | 130 |
Why?
| Spectrophotometry | 1 | 1998 | 53 |
Why?
| Antigens, CD31 | 1 | 1998 | 17 |
Why?
| Transplantation, Homologous | 3 | 1980 | 94 |
Why?
| Combined Modality Therapy | 2 | 1995 | 219 |
Why?
| Cell Transformation, Neoplastic | 3 | 1980 | 86 |
Why?
| Semen | 1 | 1977 | 15 |
Why?
| Genes, p53 | 1 | 1997 | 43 |
Why?
| Leukocyte Count | 2 | 1984 | 94 |
Why?
| Hypoxia, Brain | 1 | 1997 | 15 |
Why?
| Antibody Specificity | 3 | 1980 | 71 |
Why?
| Phenylhydrazines | 1 | 1996 | 2 |
Why?
| Hydralazine | 1 | 1996 | 7 |
Why?
| Organoplatinum Compounds | 1 | 1996 | 6 |
Why?
| DNA Adducts | 1 | 1996 | 12 |
Why?
| DNA-Directed DNA Polymerase | 2 | 1986 | 18 |
Why?
| DNA Polymerase II | 2 | 1984 | 8 |
Why?
| Regional Blood Flow | 1 | 1997 | 105 |
Why?
| CTLA-4 Antigen | 1 | 1995 | 10 |
Why?
| Vasodilator Agents | 1 | 1996 | 56 |
Why?
| Animals, Newborn | 4 | 1997 | 175 |
Why?
| Anemia | 1 | 1996 | 60 |
Why?
| Eosinophils | 1 | 1995 | 30 |
Why?
| Antigens, Differentiation | 1 | 1995 | 53 |
Why?
| Brain Ischemia | 1 | 1997 | 45 |
Why?
| Trypsin Inhibitor, Bowman-Birk Soybean | 1 | 1995 | 2 |
Why?
| Interleukins | 1 | 1995 | 32 |
Why?
| Transcription, Genetic | 2 | 1992 | 253 |
Why?
| Biological Markers | 1 | 1998 | 262 |
Why?
| Molecular Weight | 4 | 1977 | 154 |
Why?
| Autoimmune Diseases | 1 | 1975 | 49 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1995 | 38 |
Why?
| Dose-Response Relationship, Immunologic | 3 | 1980 | 37 |
Why?
| Immunosorbent Techniques | 1 | 1993 | 22 |
Why?
| Thymidine Kinase | 1 | 1993 | 15 |
Why?
| Ganciclovir | 1 | 1993 | 18 |
Why?
| Transduction, Genetic | 2 | 2001 | 65 |
Why?
| Simplexvirus | 1 | 1993 | 33 |
Why?
| Magnetics | 1 | 1993 | 30 |
Why?
| Antigens, CD | 1 | 1995 | 128 |
Why?
| Staining and Labeling | 2 | 1987 | 101 |
Why?
| Neoplastic Stem Cells | 2 | 1986 | 21 |
Why?
| Transplantation, Isogeneic | 2 | 1980 | 21 |
Why?
| T-Lymphocyte Subsets | 1 | 1993 | 70 |
Why?
| Genetic Vectors | 2 | 2001 | 139 |
Why?
| Liver | 1 | 1997 | 248 |
Why?
| Chickens | 3 | 1975 | 81 |
Why?
| Antibody Formation | 3 | 1975 | 89 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 9 |
Why?
| Perfusion | 2 | 2001 | 73 |
Why?
| Brain | 1 | 1999 | 305 |
Why?
| Ascitic Fluid | 2 | 1975 | 20 |
Why?
| Immunoblotting | 1 | 2011 | 119 |
Why?
| Interferons | 1 | 1990 | 39 |
Why?
| Immune Sera | 1 | 1989 | 56 |
Why?
| Binding, Competitive | 1 | 1989 | 109 |
Why?
| Thymus Gland | 2 | 1984 | 57 |
Why?
| Promoter Regions, Genetic | 1 | 1992 | 188 |
Why?
| RNA, Messenger | 5 | 1988 | 394 |
Why?
| Poly I-C | 1 | 1988 | 7 |
Why?
| Sheep | 3 | 1975 | 46 |
Why?
| Immunologic Deficiency Syndromes | 1 | 1988 | 30 |
Why?
| Papio | 2 | 1997 | 12 |
Why?
| Neutrophils | 1 | 1990 | 114 |
Why?
| Partial Pressure | 2 | 1997 | 30 |
Why?
| DNA, Neoplasm | 1 | 1987 | 75 |
Why?
| Cell Aggregation | 1 | 1987 | 25 |
Why?
| Histocompatibility Antigens | 1 | 2007 | 17 |
Why?
| Immunologic Memory | 2 | 1980 | 51 |
Why?
| Luciferases | 1 | 2007 | 70 |
Why?
| Fetal Blood | 1 | 1987 | 54 |
Why?
| Culture Media | 1 | 1987 | 116 |
Why?
| Bromelains | 2 | 1975 | 1 |
Why?
| Mice, Inbred NZB | 2 | 1975 | 2 |
Why?
| Tissue Distribution | 2 | 1996 | 124 |
Why?
| Radioimmunoassay | 1 | 1986 | 81 |
Why?
| Horses | 2 | 1975 | 18 |
Why?
| Iodine Radioisotopes | 1 | 1986 | 64 |
Why?
| Isoantibodies | 1 | 1985 | 25 |
Why?
| Biopsy | 1 | 2007 | 207 |
Why?
| Antigens, Thy-1 | 1 | 1986 | 22 |
Why?
| DNA | 3 | 1977 | 262 |
Why?
| Whole-Body Irradiation | 1 | 1986 | 43 |
Why?
| Receptors, Mitogen | 1 | 1985 | 8 |
Why?
| Nuclear Proteins | 1 | 1989 | 139 |
Why?
| Proliferating Cell Nuclear Antigen | 2 | 1989 | 26 |
Why?
| RNA, Neoplasm | 2 | 1993 | 41 |
Why?
| Cell Fusion | 1 | 1984 | 19 |
Why?
| Rabbits | 1 | 1986 | 252 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 1984 | 23 |
Why?
| Isoenzymes | 1 | 1986 | 144 |
Why?
| Protein Biosynthesis | 1 | 1985 | 113 |
Why?
| Immunization, Secondary | 2 | 1977 | 31 |
Why?
| Chromium Radioisotopes | 1 | 2001 | 7 |
Why?
| Coculture Techniques | 1 | 2001 | 59 |
Why?
| Tumor Stem Cell Assay | 1 | 2001 | 21 |
Why?
| Hot Temperature | 1 | 1982 | 93 |
Why?
| Vagina | 1 | 2001 | 30 |
Why?
| Sequence Deletion | 1 | 2001 | 88 |
Why?
| Aging | 1 | 2007 | 275 |
Why?
| Virion | 1 | 2001 | 24 |
Why?
| Base Sequence | 2 | 1992 | 371 |
Why?
| Rats, Inbred BUF | 1 | 2000 | 5 |
Why?
| Mucous Membrane | 1 | 2000 | 37 |
Why?
| Submandibular Gland | 1 | 2000 | 20 |
Why?
| Injections, Subcutaneous | 1 | 2000 | 63 |
Why?
| Administration, Oral | 1 | 2001 | 170 |
Why?
| Niacinamide | 1 | 2000 | 8 |
Why?
| Administration, Topical | 1 | 2000 | 57 |
Why?
| Liver Neoplasms, Experimental | 1 | 2000 | 21 |
Why?
| Tomography, Emission-Computed | 1 | 2000 | 25 |
Why?
| Granulocytes | 1 | 1980 | 46 |
Why?
| Dose Fractionation | 1 | 2000 | 25 |
Why?
| Molecular Sequence Data | 2 | 1992 | 404 |
Why?
| Laminin | 1 | 1999 | 40 |
Why?
| Mutagenesis, Site-Directed | 1 | 2001 | 126 |
Why?
| Recombinant Fusion Proteins | 1 | 2001 | 189 |
Why?
| Proteoglycans | 1 | 1999 | 45 |
Why?
| Drug Combinations | 1 | 1999 | 95 |
Why?
| Rats, Inbred WKY | 1 | 1999 | 15 |
Why?
| Rats, Inbred F344 | 1 | 2000 | 80 |
Why?
| Epithelial Cells | 1 | 2001 | 135 |
Why?
| Constriction, Pathologic | 1 | 1999 | 65 |
Why?
| Ischemia | 1 | 1999 | 65 |
Why?
| In Situ Nick-End Labeling | 1 | 1999 | 65 |
Why?
| Thalamus | 1 | 1999 | 23 |
Why?
| Interphase | 2 | 1987 | 26 |
Why?
| Hypothalamus | 1 | 1999 | 33 |
Why?
| Transgenes | 1 | 1998 | 56 |
Why?
| Cricetulus | 2 | 1987 | 39 |
Why?
| Functional Laterality | 1 | 1999 | 50 |
Why?
| Heart Defects, Congenital | 1 | 1999 | 55 |
Why?
| Antibodies, Viral | 1 | 2001 | 104 |
Why?
| Enhancer Elements, Genetic | 1 | 1998 | 43 |
Why?
| Killer Cells, Lymphokine-Activated | 1 | 1997 | 7 |
Why?
| Models, Genetic | 1 | 1998 | 90 |
Why?
| Collagen | 1 | 1999 | 118 |
Why?
| Gestational Age | 1 | 1999 | 114 |
Why?
| Ovary | 2 | 1987 | 50 |
Why?
| Oxidation-Reduction | 1 | 1999 | 124 |
Why?
| Genitalia, Male | 1 | 1997 | 12 |
Why?
| Corpus Striatum | 1 | 1999 | 48 |
Why?
| Insemination | 1 | 1977 | 2 |
Why?
| Spermatozoa | 1 | 1977 | 25 |
Why?
| Tetanus Toxoid | 1 | 1977 | 27 |
Why?
| Hippocampus | 1 | 1999 | 83 |
Why?
| Clinical Laboratory Techniques | 1 | 1997 | 31 |
Why?
| Lectins | 1 | 1977 | 18 |
Why?
| Binding Sites | 1 | 2000 | 213 |
Why?
| DNA Polymerase III | 2 | 1986 | 12 |
Why?
| Chromatography, Gel | 1 | 1977 | 61 |
Why?
| Restriction Mapping | 1 | 1997 | 74 |
Why?
| Mitogens | 1 | 1977 | 31 |
Why?
| Diffusion | 1 | 1997 | 49 |
Why?
| Autoantibodies | 1 | 1977 | 64 |
Why?
| Organ Specificity | 1 | 1997 | 104 |
Why?
| Transplantation, Heterologous | 1 | 1997 | 57 |
Why?
| Acute Disease | 1 | 1999 | 271 |
Why?
| Injections, Intravenous | 1 | 1997 | 105 |
Why?
| Cerebral Cortex | 1 | 1999 | 108 |
Why?
| Microscopy, Immunoelectron | 1 | 1996 | 22 |
Why?
| Chronic Disease | 1 | 1999 | 267 |
Why?
| Species Specificity | 1 | 1977 | 186 |
Why?
| Organoids | 1 | 1995 | 8 |
Why?
| Antilymphocyte Serum | 1 | 1975 | 22 |
Why?
| Antibody-Producing Cells | 1 | 1975 | 20 |
Why?
| DNA Primers | 1 | 1997 | 208 |
Why?
| Reference Values | 1 | 1997 | 278 |
Why?
| In Situ Hybridization | 1 | 1995 | 135 |
Why?
| Gene Therapy | 1 | 1997 | 89 |
Why?
| Polymerase Chain Reaction | 1 | 1997 | 279 |
Why?
| Cattle | 2 | 1984 | 176 |
Why?
| Prognosis | 1 | 1997 | 388 |
Why?
| Predictive Value of Tests | 1 | 1996 | 321 |
Why?
| Rats, Sprague-Dawley | 1 | 1997 | 257 |
Why?
| Sensitivity and Specificity | 1 | 1997 | 427 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 1995 | 126 |
Why?
| Neoplasm Invasiveness | 1 | 1993 | 105 |
Why?
| Blotting, Western | 1 | 1995 | 275 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 21 |
Why?
| Nucleic Acid Hybridization | 1 | 1989 | 94 |
Why?
| beta 2-Microglobulin | 1 | 1988 | 17 |
Why?
| Blotting, Northern | 1 | 1989 | 151 |
Why?
| Deoxyribonuclease I | 1 | 1987 | 16 |
Why?
| Cloning, Molecular | 1 | 1989 | 183 |
Why?
| Aged | 1 | 2000 | 988 |
Why?
| Immunity, Innate | 1 | 1988 | 60 |
Why?
| Aphidicolin | 1 | 1986 | 3 |
Why?
| Deoxyguanine Nucleotides | 1 | 1986 | 4 |
Why?
| Diterpenes | 1 | 1986 | 6 |
Why?
| Middle Aged | 1 | 2000 | 1161 |
Why?
| Adult | 1 | 2000 | 1317 |
Why?
| Adenosine Triphosphate | 1 | 1986 | 121 |
Why?
| Chromatography, Affinity | 1 | 1984 | 49 |
Why?
| RNA | 1 | 1988 | 126 |
Why?
| Cell Membrane | 1 | 1984 | 170 |
Why?
| Cytological Techniques | 1 | 1982 | 18 |
Why?
| Trinitrobenzenes | 1 | 1981 | 4 |
Why?
| Concanavalin A | 1 | 1981 | 25 |
Why?
| Receptors, Fc | 1 | 1981 | 28 |
Why?
| Fluoresceins | 1 | 1981 | 50 |
Why?
| Lipopolysaccharides | 1 | 1981 | 98 |
Why?
| Binding Sites, Antibody | 1 | 1977 | 28 |
Why?
|
|
Lord's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
